How Much Does Tirzepatide Cost in 2026?

The short answer: In 2026, compounded tirzepatide from U.S. telehealth programs runs roughly $195 to $549 per month before discounts, and several add a separate membership fee. The lowest-priced flat programs start near $195/mo and fall to about $150/mo on a 12-month plan. Branded, FDA-approved tirzepatide (Zepbound®) typically costs more at cash price. Compounded tirzepatide is not FDA-approved.

The 2026 tirzepatide price landscape

There is no single “tirzepatide price.” What you pay depends on whether you choose a compounded program or the branded product, whether the program charges a membership fee, and whether the price is flat or rises with your dose. Across the compounded telehealth programs we track, the monthly medication cost sits roughly between $195 and $549 before any first-order discount — a spread of more than two-to-one for what is nominally the same molecule.

That wide range is the single most important thing to understand about tirzepatide pricing. A program at the bottom of the range and one at the top are not selling meaningfully different medication quality that you can verify from the price alone — because compounded tirzepatide is not FDA-approved, the compounding pharmacy is the real quality signal, not the sticker. So the practical job is to compare the all-in monthly cost honestly, and that means seeing past the headline number.

What compounded tirzepatide programs charge

The table below lists the monthly compounded tirzepatide price for programs in our comparison, along with how each one structures the cost. These are the programs' own published figures as of June 2026. Where a program adds a membership fee or tiers the price by dose, the “how it's priced” column says so — because a low medication price plus a fee can beat or lose to a higher flat price depending on the numbers.

Program	Tirzepatide / mo	How it's priced	Membership
MLMaxLifeFlat all-in	$195/mo$150 (12-mo)	Flat price, no per-dose upcharge	$0
MoMochi HealthVideo visits + dietitian	$199/mo+ membership	Medication price plus a monthly membership	+ membership
EmEmergeDose-tiered · tirz-only	$287–419by dose	Price rises as your dose increases	$0
TrTrimRxFlat all-in + guarantee	$349/mo$283 (12-mo)	Flat price, discount on longer plan	$0
FeFella HealthMen-focused program	$399/mo$249 (3-mo)	Flat price, discount on 3-month plan	$0

Prices are each program's own published figures, sourced June 2026 through a tirzepatide lens, and change frequently — verify live on each program's site before deciding. “+ membership” means a separate recurring fee applies on top of the medication price; “by dose” means the monthly cost rises as you titrate up. See our methodology for how we source and label these figures.

What actually drives the price

The gap between a $195 program and a $549 program is mostly structure, not medication. Four factors move the number the most, and understanding them lets you compare programs on the same footing rather than on marketing.

Membership fees. Several programs advertise a low medication price and then bill a separate monthly membership — commonly in the $75 to $135 range. A $99 medication price with a $79 membership is $178 all-in, which changes the comparison entirely. Always add any membership fee to the medication price before ranking programs by cost.

Dose tiering. Some programs charge a flat price regardless of dose; others raise the price as you titrate up. Because tirzepatide is stepped up over months toward a maintenance dose of up to 15 mg (see our dosing guide), a dose-tiered program's entry price can climb well above what you first saw. Emerge, for example, publishes a $287–$419 range that tracks your dose. Willow's tirzepatide is dose-tiered too, climbing to about $549 at higher doses.

Plan length. Many programs discount the monthly rate if you prepay for 3, 6, or 12 months. MaxLife's tirzepatide drops from $195 to $150/mo on a 12-month plan; TrimRx drops from $349 to $283. The trade-off is committing cash up front for a treatment a clinician may adjust or stop, so weigh the discount against the flexibility you give up.

Quiz-gated pricing. A few programs do not publish an exact tirzepatide price at all until you complete an intake questionnaire, which makes upfront comparison hard. Treat an unpublished price as a reason to confirm the all-in monthly cost — including any membership — before you enroll.

Compounded vs. branded Zepbound® cost

The prices above are for compounded tirzepatide. Branded, FDA-approved tirzepatide — Eli Lilly's Zepbound® for weight management and Mounjaro® for type 2 diabetes — is a separate product with its own pricing. At cash price, branded tirzepatide has generally been higher than compounded programs, which is a large part of why cash-pay patients turned to compounded options in the first place.

But cash price is not the only path. If your insurance covers branded tirzepatide, or if you qualify for the manufacturer's savings or self-pay programs, the branded product can end up cheaper — and it carries the assurance of FDA approval that compounded versions do not. The right cost comparison therefore is not simply “compounded is cheaper.” It is: your all-in compounded price versus your actual out-of-pocket branded price after insurance and any savings program. Confirm branded pricing and coverage directly with the manufacturer, your pharmacy, and your insurer, because those figures move and are specific to you.

How to compare tirzepatide prices honestly

To get a real number you can compare across programs, do four things. First, add any membership fee to the medication price. Second, ask whether the price holds at your target maintenance dose, not just the starting dose. Third, check the plan length a discounted rate requires and whether you can cancel. Fourth, look past price to the pharmacy — because compounded tirzepatide is not FDA-approved, a program that names its licensed compounding pharmacy and can supply a certificate of analysis is giving you something the sticker price cannot.

On our rubric, pricing transparency and pharmacy disclosure each carry 25% of the score for exactly this reason — together they are half of what makes a tirzepatide program trustworthy. Our methodology explains the full weighting, and the 2026 rankings show how each program scores.

The bottom line

In 2026, compounded tirzepatide costs roughly $195 to $549 per month across the programs we track, with the lowest published flat entry price at $195/mo ($150/mo on a 12-month plan). The number you actually pay depends on membership fees, dose tiering, and plan length — so compare all-in monthly cost, confirm the price holds at your maintenance dose, and weigh the pharmacy's transparency, not just the price. Branded Zepbound® is a separate, FDA-approved option whose real cost depends on your insurance. Compounded tirzepatide is not FDA-approved, and a licensed provider decides whether treatment is right for you.